Cytogenetic Analysis and Clinical Phenotype of Primary Amenorrhea in Indonesian Patients by Ali, Aisha Balkhar et al.
 J.Biomed.Transl. Res 
ISSN: 2503-2178 
 
JOURNAL OF BIOMEDICINE AND 
TRANSLATIONAL RESEARCH 
 
Copyright©2018 by Faculty of Medicine Diponegoro University and Indonesian Medical Association, Central Java Region 
 
Cytogenetic Analysis and Clinical Phenotype of Primary Amenorrhea 
in Indonesian Patients  
 
Aisha Ali1*, Rita Indriyati2, Tri Indah Winarni2, Sultana MH Faradz2  
 
1Student of Genetic Counseling, Master of Biomedical Science, Faculty of Medicine Diponegoro University,    
Semarang, Central-Java, Indonesia   
2Center for Biomedical Research (CEBIOR), Faculty of Medicine Diponegoro University, Semarang, Central- 
Java, Indonesia 
 
Article Info 
History: 
Received: 19 Apr 2018 
Accepted: 06 July 2018 
Available: 31 July 2018 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
Background: Primary amenorrhea (PA) is a symptom that can be caused by 
different disorders such as gonadal, endocrinal, physiological and genetic 
disorders.   
Objectives: This study provided the clinical and cytogenetic profiles of Indonesian 
primary amenorrhea patients and matching the clinical criteria of those patients 
with their karyotype results by using a new scoring system. 
Methods: A retrospective descriptive study of 79 PA patients, whom referred to 
Cytogenetic and Molecular unit Center for Biomedical Research (CEBIOR), 
Faculty of Medicine Diponegoro University. We made a scoring system consisted 
of 4 scores, all patients had been distributed to match the scores according to their 
clinical criteria’s and then confirmed with the karyotype results.    
Results: The karyotype results of 79 patients of PA revealed 55 (69.6%) patients 
with female karyotype 46,XX; 6 (7.6%) patients with male karyotype 46,XY; 
8(10.1%) patients with monosomy X; 3 (3.8%) patients with 45,X/46,XX; 3 
(3.8%) patients with  Isochromosome 45 X/46, X,i(Xq). Mosaicism with  Y  
constitution 45,X/46,XY  was seen in 2 (2.5%) patients;  marker chromosome 
45,X/46,X+mar (2%) in 1 patient (1.3%); and  chromosome 1 and  X translocation 
46,XX,t(1;X)(p34;q25) detected in   
1(1.3%) patient. Scoring system results showed that all patients with normal 
karyotype (46,XX/46,XY) were matched with score 1 and 2 while 17 patients with 
chromosomal abnormalities were matched with score 3 and 4, only 1 patient with 
mosaic Turner syndrome 45,X(10%)/46,XX(90%) matched score 1.   
Conclusion: Turner syndrome was the most common cause of primary 
amenorrhea, which attests the importance of cytogenetic analysis for diagnosis of 
primary amenorrhea patients. The scoring system needs further validation for 
measuring reliability and validity.   
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INTRODUCTION 
Primary amenorrhea defined as failure of 
menarche, associated with undeveloped secondary 
sexual signs by age 14, or failure of menarche with 
well-developed secondary sexual signs by age 16.1It is 
a symptom that caused by different disorders.2,3 The 
worldwide incidence estimated to be 1%,4,5 and based 
on research results from different countries, there was 
no evidence for higher frequency in a specific 
population or ethnic group.3 
A number of studies estimated  the frequency of 
primary amenorrhea based on the  causes including 
gonadal dysgenesis was due to chromosomal 
abnormalities as the largest cause accounting in 45%, 
followed by Mayer  Rokitanski  Kuser Hauser  
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syndrome (MRKH) in 15%, and Hypothalamic 
Idiopathic HypogonadotropicHypogonadism (IHH) 
was estimated to be 15%. Complete androgen 
insensitivity syndrome (CAIS) assessed for 10% of all 
primary amenorrhea patients,7 imperforated hymen 
and transverse septum hymen reported to be 5%,8 
while the remaining 5% was distributed among 
congenital adrenal hyperplasia (CAH) and ovarian 
insensitivity syndrome.3Mullerian Agenesis-Mayer 
Rokitansky-Kuster-Hauser Syndrome (MRKH) has a 
prevalence of 1:5000 female births.6 Affected 
individuals have a 46,XX karyotyping and a normal 
secondary sex characteristics. Type A (MRKA) 
patients show Symmetric uterine buds and fallopian 
tubes. Type B (MRKH) shows asymmetric uterine 
buds and fallopian tubes and being associated with 
other congenital anomalies (skeletal, renal, ovarian, 
ear and cardiac).6,9 
This is the first study in Indonesia to provide the 
profiles of primary amenorrhea patients including the 
karyotype results and their clinical profiles. The new 
of this study that we made a scoring system and the 
patients had been distributed to match the scores 
according to their clinical criteria and then confirmed 
it with their karyotype results.This scoring system can 
help to distinguish roughly possible karyotype results 
in situation of deficient genetic facilities before 
cytogenetic analysis hold out. Scoring system can be 
used to predict that PA patient with normal secondary 
sexual signs can be female or male karyotype results 
and cannot be a chromosomal abnormality based on 
clinical phenotypes. In contrast, PA with poor 
secondary sexual development with short stature and 
web neck can predict of chromosomal abnormalities.  
However, this scoring system still needs further 
studies to measure validity and reliability, and 
whether it could be used as a tool to predict the 
clinical phenotype and the genetic cause/karyotype. 
 
METHODS  
Population and Sample   
The sampling method was purposive sampling; 
patients had been selected according to the purpose of 
the study. All patients who referred to CEBIOR with 
primary amenorrhea and had available data, with the 
criteria: thirteen years old with undeveloped 
secondary sexual signs or 16 years old with well-
developed secondary sexual signs. All patients with  
inclusioncriteria Whom referred to Cytogenetic and 
Molecular unit Center for Biomedical Research 
(CEBIOR), Facultyof Medicine Diponegoro 
University from the period of January 2004 to January 
2017  were included in this study. 
In this study we made a  scoring system consisted 
of  clinical criteria and karyotype results the score 
system had 4 scores,  score 1 for primary amenorrhea 
symptom only, score 2 for primary amenorrhea and 
poor secondary sexual signs, score 3 for primary 
amenorrhea, poor secondary sexual signs and short 
stature, score 4 for  primary amenorrhea, poor 
secondary sexual signs, short stature, and webbed 
neck. The clinical data was obtained from the medical 
records and were grouped into the scoring system. 
Patients without complete cytogenetic and clinical 
data were excluded.  All the patients had been 
distributed to match the scores according to their 
clinical profiles and then confirmed with the 
karyotype results. 
Poor secondary sexual signs considered if Tanner 
stage less than 4 with spare or absent axillary hair. 
Short stature considered if the height is below 2 
slandered deviation of the mid parental hight.  
Chromosomal analysis had been performed by 
blood as a usual method in CEBIOR.  
 
Table 1. Scoring system for primary amenorrhea 
patients 
PA= primary amenorrhea   
Poor secondary sexual signs = Tanner stage less than 4 with 
spare or abscent axillary hair 
 
 
RESULTS  
Seventy nine PA patients were included in this 
study. The distribution of patients according to the 
karyotype revealed that 55 (69.6%) of patients had 46, 
XX karyotype; 6 (7.6%) patients had 46, XY 
karyotype, and 18 (22.8%) patients with chromosomal 
abnormalities as showed in Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The most frequent chromosomal abnormalities 
was 45,X in 10.1% followed by 45,X/46,XX 
mosaicism in 3.7%. Isochromosomemosaicism of 
45,X/46,X,i(Xq) accounted in 3.8%. Mosaicism with 
Y constitution 45,X/46,XY  was found in 2 patients 
2.5%;  marker chromosome 45,X/46,X +mar (2%) in 
1 patient and  chromosome 1 and  X translocation 
46,XX,t(1;X)(p34;q25) detected in 1 patient. The 
Score Clinical Criteria 
1   PA   
2   PA, poor secondary sexual development   
3   PA, poor secondary sexual development and short  
stature   
4   PA, poor secondary development, short stature, 
webbed neck.   
Figure 1. Distribution of karyotype results in primary 
amenorrhea patients 
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Karyotype results of all the patients showed in Table 
2. 
 
Table 2. The karyotype results of 79 patients with 
primary amenorrhea. 
 
The distribution of diagnosis among 55 patients 
with female karyotype 46, XX revealed 14 patients 
with MRKH, 2 patients with CAH and 1 patient with 
pure gonadal dysgenesis, while the remaining 38 
patients still with unknown diagnosis. The diagnosis 
among 6 PA patients with male karyotype, 2 were 
CAIS, 1 was PAIS, and 3 patients with pure gondal 
dysgenesis (PGD) of undetermined cause.  
According to the cytogenetic results of 18 patients 
with chromosomal abnormalities, the diagnosis were 
classical Turner Syndrome in 8 patients, mosaic 
Turner Syndrome in 9 patients and 1 patient with 
autosomal X translocation. The distribution of 
diagnosis among all patients showed in Figure 3. 
 
 
 
 
 
 
 
The result of scoring system and their karyotype 
revealed that scored 1 which was presented with 
primary amenorrhea only were 30 patients with 
female karyotype (46,XX); 1 patient with male 
karyotype 46,XY; and 1 patient with mosaic Turner 
Syndrome 45,X(1%)/46,XX(99%). There were 25 
patients with female karyotype (46,XX) and 5 patients 
with male karyotype (46,XY) matched with score 2.  
Score 3 was demonstrated in 4 patients with classical 
Turner  Syndrome (45,X); 4 patients with mosaic 
Turner (45X,46,XX) and 1 patient with karyotype  
46,XX,t(1;X)(p34;q25). In This study 4 patients 
with classical Turner Syndrome (45,X ), 3 patients 
with isochromosme 46,X,i(Xq)/45,X and 1 patient 
with marker chromosome 45,X(98%) /46,X,+mar 
(2%) were matched with score 4. (See Table 3) 
 
Table 3. Scoring system and its related karyotype. 
Score Frequency of 
Patients 
Karyotype Results 
1 30 46,XX 
 1 45,X(1%)/46.XX(99%) 
 1 46,XY 
2 25 46,XX 
 5 46,XY 
3 4 45,X 
 1 45,X(20%)/46,XX(80%) 
 1 45,X(2%)/46,XX(98%) 
 1 45,X(90%)/46,XY(10%) 
 1 45,X(80%)/46,XY(20%) 
 1 46,XX,t(1;X)(p34;q25) 
4 4 45,X 
 1 46,X,i(Xq)(10%)/45X(90%) 
 1 46,X,i(Xq)(24%)/45X(76%) 
 1 46,X,i(Xq)(20%)/45X(80%) 
 1 45,X(98%)/46,X,+mar(2%) 
 
 
DISCUSSION 
Attainment of menarche is important for female 
confidence and feminism. Primary amenorrhea can be 
a cause of psychological trauma in any female in 
reproductive age group.2 World Health Organization 
(WHO) ranked the primary amenorrhea as the sixth 
most common cause of infertility, hence the 
amenorrhea account 20% of all patients of infertility.6 
The cause of primary amenorrhea are different and the 
role of genetic factors are significant. Several studies 
Chromosomal 
Categories 
Karyotype 
Number of 
patients 
n % 
Female Karyotype 46, XX 55 69.6 
Male karyotype 46, XY 6 7.6 
Numerical 
Abnormality 
   
Monosomy X 45,X 8 10.1 
Turners Mosaic                                       45,X/46,XX 3 3.8 
Presence of XY 
constitution 
45,X/46,XY 2 2.5 
Structural 
Abnormality 
   
Marker 
chromosome                          
45,X/46,X +mar2% 1 1.3 
Isochromosome                                    45,X/46,X,i(Xq) 3 3.8 
Translocation X;1                               46,XX,t(1;X)(p34;q25) 1 1.3 
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  Figure 2. Karyotype result of patient with balanced 
translocation between 1p (arrow) and Xq (arrow) 
(46,XX,t(1;X)(p34;q25)) 
Figure 3.  Frequency of diagnosis among 40 patients 
with primary amenorrhea 
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for cytogenetic analysis of primary amenorrhea 
patients have been done and aiming to understand the 
frequency and chromosomal constitution in those 
patients.10 
 In this study we demonstrated that 22.8% (18/79) 
PA patients with chromosomal abnormalities either 
numerical or structural. However, our study 
coordinate to the world wide estimated range for 
chromosomal abnormalities among primary 
amenorhea patients. In  earlier studies  the 
chromosomal abnormalities among primary 
amenorrhea patients reported to be counted in 20.63% 
in Egyptian patients,11   27.8% in Indian 
population,1,4,12 20% in Iranian population13 and 41% 
in Mexican population.14 However, our study results 
was coordinated to the world wide estimated range for 
chromosomal abnormality among primary 
amenorrhea patients which was between 15.9% and 
63.3%.5,7,15  
All patients with sex chromosomal abnormalities 
in our study were Turner Syndrome either classical 
Turner Syndrome or Mosaic. This result was in line 
with previous studies which reported that Turner 
Syndrome is the most common observed 
chromosomal abnormality in primary amenorrhea and 
also strengthened the role of sex chromosome in the 
reproduction of female.4,9,16 
The previous result revealed that classical Turner 
Syndrome detected in 30% (16/52) of  primary 
amenorrhea patients in Turkish population,16 and 
26.9% (7/ 26) of Indian  patients.1,4,12,17In current 
study Turner syndrome was detected in 17 out of 
18.The high percentage of Turner Syndrome in our 
study could be due to patients selection and lack of 
genetic diagnostic in many referral hospitals in Java 
Island. So, most of patients referred to our center to 
do cytogenetic analysis.   
The clinical profiles of Turner Syndrome patients 
showed that all patients with classical Turner 
Syndrome had short stature. Despite short stature, 
which seems to be the general clinical characteristic 
of Turner Syndrome, all other clinical stigmata were 
inconsistent, even in individuals with classical 45,X. 
The possible explanation for this issue that the 
physical manifestations of Turner Syndrome patients 
largely depends on the karyotype.16 The cause of short 
stature in Turner Syndrome suggested to be a 
homeobox gene, short stature homeobox (SHOX) gene 
in the pseudoautosomal region 1 (PAR1) is the major 
player and that haploinsuffiency of this gene leads to 
the growth failure.16,20 The other possible cause of 
short stature in Turner syndrome is inadequate 
production ofEstrogen,many of those with Turner 
Syndrome developosteoporosis.This can decrease 
height further, as well as exacerbate the curvature of 
the spine.14,20 
Mosaic Turner Syndrome with XY constitution 
seen in 11.7% (2/17) of the patients, detection of Y 
chromosome and its component is very important due 
to the risk of gonadoblastoma since the risk is quite 
high ranging from 10 to 20%. While patients with 
mosaicism for 46,XY cell line or structural 
rearrangement of the Y chromosome mostly have 
masculinized external genitalia and are at increased 
risk for having gonadoblastoma and other gonadal 
tumor.12,20,21  Thus, early intervention  should  be done 
for orchidectomy.22 In this study we observed 1 
patient with marker chromosome 45,X(98%)/46,X 
mar(2%) with clinical profile of this patient showed 
short stature and no other dysmorphic features, 
compared to the previous study which reported severe 
phenotype manifestations in those type of Turner 
variants,16 this could be due to the low percentage of 
marker X. Although, the conventional cytogenetic 
cannot detect the origin of marker chromosome, the 
molecular cytogenetic techniques, FISH, can 
accurately detect it.16,17 In this study we observed a 
patient with translocation between chromosome 1 and 
X. Besides primary amenorrhea, patient also had short 
stature. Translocation between X chromosome and 
autosome are known very often leads to fertility 
problems including PA and clinical features of Turner 
Syndrome and variable phenotype including 
developmental delay, thus, may due to nonrandom X-
inactivation.18 Especially when involving q arm of X 
chromosome, therefore, the finding may very well 
presented a balanced translocation resulting in the 
described phenotype (see figure 2). Some candidate 
genes located in the q arm of X chromosome may 
interrupted due to X-autosome translocation such as 
DIAPH2, XPNEP2, DACH2, POF1B, CHM and 
NXF5.19 However, further cytogenetic/molecular 
analysis should be done to see  the genotype and 
phenotype association in this patient  
In our study the most common cause of primary 
amenorrhea in female karyotype patients was MRKH 
(14/55 ). The clinical profile of the patients showed 
normal Tanner stage in all patients, normal external 
genital and no dysmorphic features. With regards to 
the high number of MRKH patients, it needs 
molecular study to detect the associated gene 
mutations,23 although, the cause of mullerian gene is 
unknown, but it may be due to a mutation in the gene 
of the anti mullerian hormone or the Anti Mullerian 
Hormone (AMH) receptor. The underlying 
mechanism would be exposure to AMH acivity. No 
activating mutation is reported, in contrast with 
inactivating mutations which cause persistence of 
mullerian structures.24 
Male karyotype presented in a significant 
percentage (7.6%) of patients with primary 
amenorrhoea although they appeared to be physically 
normal with some just appearing the height is taller 
for their age. In our study Y chromosome had been 
detected in  10%  of  PA patients, compared to 
previous study which demonstrated that Y 
chromosome was observed in 20% patients that 
referred as complain of primary amenorrhea.14 
Although, this study demonstrated lower percentage, 
it could be due to selection of patients, preservation of 
some patients for karyotype analysis.  Furthermore, 
conventional cytogenetic method can missed the Y 
component up to 9.3%.21 Detection of Y chromosome 
complement and their composition is important in 
genetic counseling, because of the association with 
the risk of gonadoplastoma.9,12,20 
26 
 
 
Journal of Biomedicine and Translational Research 01 (2018) 22 - 27 
In this study the most common cause of primary 
amenorrhea was gonadal dysgenesis Turner Syndrome 
followed by MRKH, pure gonadal dysgenesis, CAH, 
CAIS and PAIS. The remaining 39 (49.3%) patients 
still not diagnosed, it could be due to mutations and 
need molecular analysis for establishing the diagnosis. 
This study was agree with study in United States 
which demonstarated that gonadal dysgenesis as the 
commonest cause of primary amenorrhea and MRKH 
as the second most common cause.23 The same result 
had been reported from  Korean study, which reported 
that  the common causes of primary amenorrhea were 
gonadal dysgenesis (28.0%, 37/132), followed by  
MRKH syndrome (20.0%, 27/132).25 However, 
MRKH was the most prevalent cause of primary 
amenorrhea in Thailand, they reported that the 3 most 
common causes of primary amenorrhea were 
Müllerian agenesis/MRKH?  
(39.7%), gonadal dysgenesis (35.3%), and 
hypogonadotropichypogonadism (9.2%).17,20,26This 
verified that racial and environmental factors played 
an essential part in the causes of primary amenorrhea.   
In the present study we made a scoring system 
from the clinical criteria and we matched the patients 
to appropriate scores. This scoring system can help to 
distinguish roughly possible karyotype results in 
situation of deficient genetic facilities before 
cytogenetic analysis hold out. Scoring system can be 
used to predict that PA patient with normal secondary 
sexual signs can be female or male karyotype results 
and cannot be a chromosomal abnormality based on 
clinical phenotypes. In contrast, PA with poor 
secondary sexual development with short stature and 
web neck can predict of chromosomal abnormalities. 
However, this scoring system needs further study with 
large sample population and measurement for validity 
and reliability.   
A significant number of patients had sex 
chromosomal abnormalities, thus early cytogenetic 
investigation is prudent to guide further management. 
Patients with primary amenorrhea should be initially 
screened by primary physicians and gynecologists for 
presumptive diagnosis here in after, patients should 
receive prompt referral for genetic study. The reason 
for referral should be explained to the patient. If 
cytogenetic abnormalities are detected, a detail 
explanation should be given to the patient by a 
geneticist or gynecologist with experience in genetics. 
Counseling session should include the risk of 
premature ovarian failurefor patients withTurner’s 
syndrome and the use of hormonal replacement 
therapy, the possibility of infertility in the future 
patients with mosaic Turner and the risk of gonadal 
malignancy for patients with XY gonadal dysgenesis. 
Counseling should be performed tactfully, bearing in 
mind that sensitive issues related to femininity are 
involved. An experienced counselor and clinical 
psychologist if needed would be helpful when patient 
facing with the gender identity.   
 
CONCLUSION   
Turner syndrome is the most common cause of 
primary amenorrhea in patients with chromosomal 
abnormalities. Cytogenetic analysis to distinguish the 
causes of primary amenorrhea is an important step 
especially in developing countries, although 
molecular analysis is now mandatory to detect the 
gene mutation. The new scoring system needs further 
study for measuring the reliability and validity.   
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